Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Summary
This is a multi-center, randomized, double-blind, double-dummy, placebo/active-controlled study. 200 subjects undergoing abdominal surgery under general anesthesia are planned to be enrolled and randomized into the HSK55718 group, morphine group, and placebo group.
Official title: A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of HSK55718 Injection for Postoperative Pain Treatment in Abdominal Surgery
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2026-04-20
Completion Date
2027-04-20
Last Updated
2026-04-16
Healthy Volunteers
No
Conditions
Interventions
HSK55718 dose level 1
Patients administrated with HSK55718 at dose level 1
HSK55718 dose level 2
Patients administrated with HSK55718 at dose level 2
HSK55718 dose level 3
Patients administrated with HSK55718 at dose level 3
placebo
Patients administrated with placebo
morphine
Patients administrated with morphine
Locations (2)
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China